| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Randomized Controlled Trials as Topic | 3 | 2019 | 511 | 1.080 |
Why?
|
| Diet, Reducing | 5 | 2021 | 96 | 0.800 |
Why?
|
| Heart Defects, Congenital | 4 | 2020 | 31 | 0.680 |
Why?
|
| Random Allocation | 2 | 2017 | 220 | 0.670 |
Why?
|
| Smoke | 1 | 2019 | 15 | 0.670 |
Why?
|
| Diet, Carbohydrate-Restricted | 4 | 2021 | 5 | 0.670 |
Why?
|
| Food Supply | 3 | 2019 | 62 | 0.650 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 149 | 0.640 |
Why?
|
| Treatment Outcome | 10 | 2019 | 3358 | 0.600 |
Why?
|
| Cardiovascular Diseases | 4 | 2019 | 1133 | 0.590 |
Why?
|
| Humans | 46 | 2022 | 32297 | 0.540 |
Why?
|
| Confidence Intervals | 2 | 2017 | 150 | 0.530 |
Why?
|
| Body Weight | 1 | 2017 | 311 | 0.520 |
Why?
|
| Stress, Psychological | 1 | 2017 | 218 | 0.520 |
Why?
|
| Hypertension | 3 | 2021 | 972 | 0.520 |
Why?
|
| Risk Assessment | 3 | 2019 | 1447 | 0.520 |
Why?
|
| Research Design | 1 | 2017 | 313 | 0.500 |
Why?
|
| Middle Aged | 23 | 2021 | 11949 | 0.450 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2018 | 31 | 0.450 |
Why?
|
| Female | 33 | 2021 | 20126 | 0.440 |
Why?
|
| Obesity | 6 | 2021 | 1164 | 0.410 |
Why?
|
| HIV Infections | 4 | 2017 | 388 | 0.390 |
Why?
|
| Adult | 23 | 2021 | 9467 | 0.390 |
Why?
|
| Male | 28 | 2021 | 19488 | 0.390 |
Why?
|
| Socioeconomic Factors | 3 | 2019 | 422 | 0.340 |
Why?
|
| Lipids | 2 | 2021 | 226 | 0.320 |
Why?
|
| Burnout, Professional | 2 | 2021 | 50 | 0.320 |
Why?
|
| Insulin Resistance | 3 | 2022 | 460 | 0.310 |
Why?
|
| Diet, Fat-Restricted | 2 | 2018 | 30 | 0.300 |
Why?
|
| Income | 2 | 2017 | 60 | 0.300 |
Why?
|
| Aged | 13 | 2020 | 10398 | 0.290 |
Why?
|
| Retrospective Studies | 9 | 2020 | 3514 | 0.270 |
Why?
|
| Young Adult | 11 | 2021 | 2626 | 0.270 |
Why?
|
| Adolescent | 9 | 2022 | 3571 | 0.270 |
Why?
|
| Proportional Hazards Models | 4 | 2019 | 759 | 0.250 |
Why?
|
| Triglycerides | 3 | 2021 | 230 | 0.240 |
Why?
|
| Weight Loss | 4 | 2020 | 454 | 0.230 |
Why?
|
| Blood Pressure | 2 | 2019 | 859 | 0.230 |
Why?
|
| Cross-Sectional Studies | 5 | 2020 | 1522 | 0.230 |
Why?
|
| Diet Records | 2 | 2019 | 33 | 0.220 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2022 | 4 | 0.210 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2022 | 7 | 0.210 |
Why?
|
| Insulin | 3 | 2022 | 368 | 0.210 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 20 | 0.210 |
Why?
|
| Proteomics | 2 | 2020 | 94 | 0.200 |
Why?
|
| California | 5 | 2020 | 64 | 0.200 |
Why?
|
| Viral Load | 3 | 2016 | 70 | 0.200 |
Why?
|
| Algorithms | 3 | 2019 | 497 | 0.200 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 176 | 0.200 |
Why?
|
| Poverty | 2 | 2019 | 111 | 0.190 |
Why?
|
| Breast Feeding | 2 | 2018 | 43 | 0.190 |
Why?
|
| Cholesterol, Dietary | 1 | 2021 | 36 | 0.190 |
Why?
|
| Feeding Behavior | 2 | 2019 | 162 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2020 | 921 | 0.180 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 3 | 0.180 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 7 | 0.180 |
Why?
|
| United States | 5 | 2019 | 3983 | 0.180 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 141 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 244 | 0.180 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 24 | 0.180 |
Why?
|
| Proteome | 1 | 2020 | 39 | 0.180 |
Why?
|
| Mitral Valve | 1 | 2020 | 33 | 0.180 |
Why?
|
| Dental Care for Children | 1 | 2019 | 4 | 0.180 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 18 | 0.180 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2019 | 4 | 0.170 |
Why?
|
| Aortic Aneurysm | 1 | 2019 | 12 | 0.170 |
Why?
|
| Aneurysm, Dissecting | 1 | 2019 | 12 | 0.170 |
Why?
|
| Hair | 1 | 2019 | 28 | 0.170 |
Why?
|
| Pulmonary Valve | 1 | 2019 | 11 | 0.170 |
Why?
|
| Workplace | 1 | 2020 | 47 | 0.170 |
Why?
|
| Hydrocortisone | 1 | 2019 | 61 | 0.170 |
Why?
|
| Cohort Studies | 6 | 2019 | 1832 | 0.170 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 23 | 0.170 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2020 | 41 | 0.170 |
Why?
|
| Hemodynamics | 1 | 2020 | 155 | 0.170 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 188 | 0.170 |
Why?
|
| Pesticides | 1 | 2022 | 202 | 0.170 |
Why?
|
| Patient Compliance | 3 | 2017 | 227 | 0.170 |
Why?
|
| Pericardium | 1 | 2019 | 54 | 0.170 |
Why?
|
| Secondary Prevention | 1 | 2019 | 65 | 0.170 |
Why?
|
| Causality | 2 | 2019 | 39 | 0.170 |
Why?
|
| Patient Transfer | 1 | 2019 | 44 | 0.170 |
Why?
|
| Pneumonia | 1 | 2019 | 67 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 6 | 0.170 |
Why?
|
| Vegetables | 1 | 2019 | 35 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2019 | 60 | 0.170 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 11 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 759 | 0.170 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 22 | 0.170 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 10 | 0.170 |
Why?
|
| Fruit | 1 | 2019 | 53 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 121 | 0.170 |
Why?
|
| Lactation | 1 | 2018 | 15 | 0.160 |
Why?
|
| Logistic Models | 2 | 2019 | 788 | 0.160 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 72 | 0.160 |
Why?
|
| Health Status Indicators | 1 | 2019 | 74 | 0.160 |
Why?
|
| Risk Factors | 7 | 2019 | 3876 | 0.160 |
Why?
|
| Genotype | 2 | 2018 | 742 | 0.160 |
Why?
|
| Dietary Fats | 1 | 2019 | 110 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 25 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2019 | 97 | 0.160 |
Why?
|
| Models, Statistical | 1 | 2019 | 176 | 0.160 |
Why?
|
| Child | 6 | 2022 | 2472 | 0.150 |
Why?
|
| Medicare | 1 | 2019 | 206 | 0.150 |
Why?
|
| Selenium | 1 | 2017 | 4 | 0.150 |
Why?
|
| Carotenoids | 1 | 2017 | 9 | 0.150 |
Why?
|
| Marital Status | 1 | 2017 | 22 | 0.150 |
Why?
|
| Child, Preschool | 5 | 2020 | 1281 | 0.150 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 32 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2017 | 220 | 0.150 |
Why?
|
| Graft Survival | 1 | 2019 | 315 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 309 | 0.150 |
Why?
|
| Social Class | 1 | 2017 | 89 | 0.150 |
Why?
|
| Infant | 5 | 2019 | 1076 | 0.150 |
Why?
|
| Group Processes | 1 | 2017 | 15 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 56 | 0.150 |
Why?
|
| Organizational Culture | 1 | 2017 | 27 | 0.150 |
Why?
|
| Vitamins | 1 | 2017 | 68 | 0.150 |
Why?
|
| Health Expenditures | 1 | 2017 | 66 | 0.140 |
Why?
|
| Residence Characteristics | 1 | 2018 | 190 | 0.140 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 189 | 0.140 |
Why?
|
| Fasting | 1 | 2017 | 97 | 0.140 |
Why?
|
| Plasma | 1 | 2016 | 14 | 0.140 |
Why?
|
| Educational Status | 1 | 2017 | 177 | 0.140 |
Why?
|
| Milk, Human | 1 | 2016 | 16 | 0.140 |
Why?
|
| Antioxidants | 1 | 2017 | 114 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 1345 | 0.140 |
Why?
|
| Cross Infection | 1 | 2017 | 48 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 21 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2016 | 25 | 0.140 |
Why?
|
| Software | 1 | 2017 | 126 | 0.140 |
Why?
|
| Radiation Pneumonitis | 1 | 2016 | 4 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 402 | 0.140 |
Why?
|
| Prisons | 1 | 2016 | 5 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2017 | 96 | 0.140 |
Why?
|
| Prisoners | 1 | 2016 | 11 | 0.140 |
Why?
|
| Radiology Information Systems | 1 | 2016 | 14 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2017 | 184 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2017 | 131 | 0.140 |
Why?
|
| Heart Failure | 2 | 2019 | 630 | 0.130 |
Why?
|
| Continental Population Groups | 1 | 2017 | 239 | 0.130 |
Why?
|
| Smoking | 1 | 2020 | 493 | 0.130 |
Why?
|
| Carbamates | 1 | 2015 | 14 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2016 | 42 | 0.130 |
Why?
|
| Workload | 1 | 2016 | 40 | 0.130 |
Why?
|
| Internet | 1 | 2017 | 203 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 13 | 0.130 |
Why?
|
| Infant, Newborn | 4 | 2019 | 681 | 0.130 |
Why?
|
| Documentation | 1 | 2016 | 45 | 0.130 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 24 | 0.130 |
Why?
|
| Health Policy | 1 | 2016 | 85 | 0.130 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 21 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2015 | 67 | 0.130 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 54 | 0.130 |
Why?
|
| Diet | 1 | 2017 | 384 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 397 | 0.130 |
Why?
|
| Biometry | 1 | 2014 | 14 | 0.130 |
Why?
|
| Hepatitis B Vaccines | 1 | 2014 | 10 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 190 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 326 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 133 | 0.120 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 362 | 0.120 |
Why?
|
| Lung | 1 | 2016 | 262 | 0.120 |
Why?
|
| Pregnancy | 4 | 2019 | 1010 | 0.120 |
Why?
|
| Motivation | 1 | 2014 | 114 | 0.120 |
Why?
|
| Inflammation | 1 | 2017 | 542 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 124 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2019 | 788 | 0.110 |
Why?
|
| Mass Screening | 1 | 2016 | 263 | 0.110 |
Why?
|
| Radiosurgery | 1 | 2016 | 356 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 409 | 0.100 |
Why?
|
| Cytosine | 1 | 2011 | 10 | 0.100 |
Why?
|
| Adenoviridae Infections | 1 | 2011 | 13 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 51 | 0.100 |
Why?
|
| Adenoviridae | 1 | 2011 | 66 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 779 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1428 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 210 | 0.090 |
Why?
|
| Propensity Score | 2 | 2019 | 41 | 0.090 |
Why?
|
| Cholesterol, LDL | 2 | 2021 | 172 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 4050 | 0.080 |
Why?
|
| Observer Variation | 2 | 2020 | 109 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2022 | 911 | 0.080 |
Why?
|
| Energy Intake | 2 | 2019 | 128 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2019 | 355 | 0.080 |
Why?
|
| SEER Program | 2 | 2018 | 36 | 0.070 |
Why?
|
| Single-Blind Method | 2 | 2017 | 200 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 877 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 459 | 0.060 |
Why?
|
| Electronic Health Records | 2 | 2017 | 158 | 0.060 |
Why?
|
| Incidence | 2 | 2019 | 1207 | 0.060 |
Why?
|
| Time Factors | 2 | 2019 | 2181 | 0.060 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2022 | 1 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 177 | 0.050 |
Why?
|
| Health Personnel | 1 | 2021 | 121 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2022 | 534 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2019 | 4 | 0.040 |
Why?
|
| Child Behavior | 1 | 2019 | 27 | 0.040 |
Why?
|
| Tennessee | 1 | 2019 | 101 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2019 | 17 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2019 | 33 | 0.040 |
Why?
|
| Child Development | 1 | 2019 | 42 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2019 | 16 | 0.040 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2019 | 1 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 25 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2019 | 23 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2019 | 6 | 0.040 |
Why?
|
| Reminder Systems | 1 | 2019 | 22 | 0.040 |
Why?
|
| Reproductive History | 1 | 2018 | 5 | 0.040 |
Why?
|
| Parity | 1 | 2018 | 20 | 0.040 |
Why?
|
| Public Health | 1 | 2020 | 83 | 0.040 |
Why?
|
| Purines | 1 | 2019 | 21 | 0.040 |
Why?
|
| Aorta | 1 | 2019 | 126 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 71 | 0.040 |
Why?
|
| Nutrition Assessment | 1 | 2019 | 55 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2019 | 27 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 75 | 0.040 |
Why?
|
| Sirolimus | 1 | 2019 | 34 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 266 | 0.040 |
Why?
|
| Focus Groups | 1 | 2019 | 111 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 70 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 454 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2019 | 78 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 74 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 122 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 9 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2019 | 159 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2019 | 197 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 480 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2019 | 69 | 0.040 |
Why?
|
| Tocopherols | 1 | 2017 | 3 | 0.040 |
Why?
|
| Mothers | 1 | 2018 | 87 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2017 | 41 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2017 | 23 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 406 | 0.040 |
Why?
|
| Patient Selection | 1 | 2019 | 289 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2017 | 48 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 48 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2017 | 14 | 0.040 |
Why?
|
| Allied Health Personnel | 1 | 2017 | 2 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2019 | 239 | 0.040 |
Why?
|
| Nursing Staff, Hospital | 1 | 2017 | 11 | 0.040 |
Why?
|
| Nurses | 1 | 2017 | 14 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2017 | 48 | 0.040 |
Why?
|
| Mortality | 1 | 2018 | 126 | 0.040 |
Why?
|
| Health Surveys | 1 | 2017 | 202 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 894 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 309 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 102 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 786 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 1204 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2017 | 248 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 300 | 0.030 |
Why?
|
| HIV Seroprevalence | 1 | 2016 | 1 | 0.030 |
Why?
|
| New Mexico | 1 | 2016 | 6 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 101 | 0.030 |
Why?
|
| Hospitalization | 1 | 2019 | 465 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 550 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 773 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 56 | 0.030 |
Why?
|
| Overweight | 1 | 2018 | 270 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 536 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2015 | 83 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 144 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 95 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 41 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2016 | 147 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 85 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 656 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 182 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 1180 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 301 | 0.030 |
Why?
|
| Body Composition | 1 | 2016 | 384 | 0.030 |
Why?
|
| Physicians | 1 | 2017 | 161 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 196 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2016 | 161 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 496 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 600 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 161 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 986 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1523 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 469 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2296 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 410 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 2524 | 0.030 |
Why?
|
| African Americans | 1 | 2019 | 1443 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 585 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 849 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 151 | 0.020 |
Why?
|
| Exercise | 1 | 2016 | 655 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 110 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2011 | 134 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 926 | 0.020 |
Why?
|
| Animals | 1 | 2019 | 7694 | 0.020 |
Why?
|